In: Hormone Molecular Biology and Clinical Investigation, 2017, vol. 32, no. 2, p. -
|
In: Journal of Cancer Education, 2010, vol. 25, no. 1, p. 101-105
|
In: Langenbeck's Archives of Surgery, 2006, vol. 391, no. 5, p. 467-471
|
In: PLoS Comput Biol, 2015, vol. 11, no. 3, p. e1004050
Angiogenesis plays a key role in tumor growth and cancer progression. TIE-2-expressing monocytes (TEM) have been reported to critically account for tumor vascularization and growth in mouse tumor experimental models, but the molecular basis of their pro-angiogenic activity are largely unknown. Moreover, differences in the pro-angiogenic activity between blood circulating and tumor infiltrated TEM...
|
In: Cancer Research, 2011, vol. 71, no. 11, p. 3781-3791
Tumor-mobilized bone marrow-derived CD11b+ myeloid cells promote tumor angiogenesis, but how and when these cells acquire proangiogenic properties is not fully elucidated. Here we show that CD11b+ myelomonocytic cells develop proangiogenic properties during their differentiation from CD34+ hematopoietic progenitors and that Placenta Growth Factor (PlGF) is critical in promoting this ...
|